CARDIOVASCULAR SYSTEMS INC (CSII) Stock Price, Quote, News and Overview
NASDAQ:CSII - Nasdaq - US1416191062 - Common Stock - Currency: USD
CSII Quote, Performance and Key Statistics
20
+0.03 (+0.15%)
The current stock price of CSII is 20 USD. In the past month the price increased by 0.81%. In the past year, price increased by 6.95%.
CSII Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About CSII
Company Profile
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 725 full-time employees. The company went IPO on 2006-06-28. The firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The firm has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
Company Info
CARDIOVASCULAR SYSTEMS INC
1225 Old Hwy 8 Nw
ST. PAUL MINNESOTA 55112 US
CEO: Scott R. Ward
Employees: 725
Company Website: https://csi360.com/
Phone: 16512591600.0
CARDIOVASCULAR SYSTEMS INC / CSII FAQ
What is the stock price of CARDIOVASCULAR SYSTEMS INC today?
The current stock price of CSII is 20 USD. The price increased by 0.15% in the last trading session.
What is the ticker symbol for CARDIOVASCULAR SYSTEMS INC stock?
The exchange symbol of CARDIOVASCULAR SYSTEMS INC is CSII and it is listed on the Nasdaq exchange.
On which exchange is CSII stock listed?
CSII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CARDIOVASCULAR SYSTEMS INC stock?
12 analysts have analysed CSII and the average price target is 17.75 USD. This implies a price decrease of -11.26% is expected in the next year compared to the current price of 20. Check the CARDIOVASCULAR SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CARDIOVASCULAR SYSTEMS INC worth?
CARDIOVASCULAR SYSTEMS INC (CSII) has a market capitalization of 839.18M USD. This makes CSII a Small Cap stock.
How many employees does CARDIOVASCULAR SYSTEMS INC have?
CARDIOVASCULAR SYSTEMS INC (CSII) currently has 725 employees.
What are the support and resistance levels for CARDIOVASCULAR SYSTEMS INC (CSII) stock?
CARDIOVASCULAR SYSTEMS INC (CSII) has a support level at 19.98 and a resistance level at 20.01. Check the full technical report for a detailed analysis of CSII support and resistance levels.
Is CARDIOVASCULAR SYSTEMS INC (CSII) expected to grow?
The Revenue of CARDIOVASCULAR SYSTEMS INC (CSII) is expected to grow by 8.64% in the next year. Check the estimates tab for more information on the CSII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CARDIOVASCULAR SYSTEMS INC (CSII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CSII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CSII, evaluating the profitability, health, valuation and growth aspects
- CARDIOVASCULAR SYSTEMS INC (CSII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CARDIOVASCULAR SYSTEMS INC (CSII) Sales and EPS estimates to see what analysts future expectations are.
- CARDIOVASCULAR SYSTEMS INC (CSII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CARDIOVASCULAR SYSTEMS INC (CSII) Insider and Institutional Ownership to learn about the owners and their transactions.
- CARDIOVASCULAR SYSTEMS INC (CSII) Stock Chart to make your own analysis
- CARDIOVASCULAR SYSTEMS INC (CSII) Latest news and press-releases to stay up to date.
Does CARDIOVASCULAR SYSTEMS INC (CSII) stock pay dividends?
CSII does not pay a dividend.
When does CARDIOVASCULAR SYSTEMS INC (CSII) report earnings?
CARDIOVASCULAR SYSTEMS INC (CSII) will report earnings on 2023-07-31, after the market close.
What is the Price/Earnings (PE) ratio of CARDIOVASCULAR SYSTEMS INC (CSII)?
CARDIOVASCULAR SYSTEMS INC (CSII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.97).
CSII Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CSII. When comparing the yearly performance of all stocks, CSII is one of the better performing stocks in the market, outperforming 94.88% of all stocks.
CSII Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CSII. The financial health of CSII is average, but there are quite some concerns on its profitability.
CSII Financial Highlights
Over the last trailing twelve months CSII reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS decreased by -46.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.08 |
CSII Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to CSII. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 28.21% and a revenue growth 8.64% for CSII